Arii S - Search Results

1

The importance of clinical information in patients with gastroenteropancreatic neuroendocrine tumor.

Kudo A, Akashi T, Kumagai J, Ban D, Inokuchi M, Kojima K, Kawano T, Tanaka S, Arii S. Kudo A, et al. Among authors: arii s. Hepatogastroenterology. 2012 Nov-Dec;59(120):2450-3. doi: 10.5754/hge12274. Hepatogastroenterology. 2012. PMID: 22584507

2

Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies.

Tanaka S, Arii S. Tanaka S, et al. Among authors: arii s. J Gastroenterol. 2011 Mar;46(3):289-96. doi: 10.1007/s00535-011-0387-9. Epub 2011 Feb 25. J Gastroenterol. 2011. PMID: 21350811 Review.

3

Prognoses of GEP-NETS with undetermined malignant potentials of their primary sites.

Kudo A, Ban D, Akashi T, Kumagai J, Aihara A, Inokuchi M, Kojima K, Kawano T, Tanaka S, Arii S. Kudo A, et al. Among authors: arii s. Hepatogastroenterology. 2012 Sep;59(118):1682-6. doi: 10.5754/hge12275. Hepatogastroenterology. 2012. PMID: 22584425

4

Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study.

Kudo A, Mogushi K, Takayama T, Matsumura S, Ban D, Irie T, Ochiai T, Nakamura N, Tanaka H, Anzai N, Sakamoto M, Tanaka S, Arii S. Kudo A, et al. Among authors: arii s. J Gastroenterol. 2014 Mar;49(3):502-10. doi: 10.1007/s00535-013-0791-4. Epub 2013 Mar 30. J Gastroenterol. 2014. PMID: 23543312

5

Anatomic resection reduces the recurrence of solitary hepatocellular carcinoma ≤5 cm without macrovascular invasion.

Kudo A, Tanaka S, Ban D, Matsumura S, Irie T, Nakamura N, Arii S. Kudo A, et al. Among authors: arii s. Am J Surg. 2014 Jun;207(6):863-9. doi: 10.1016/j.amjsurg.2013.06.009. Epub 2013 Oct 8. Am J Surg. 2014. PMID: 24112679

6

Alcohol consumption and recurrence of non-B or non-C hepatocellular carcinoma after hepatectomy: a propensity score analysis.

Kudo A, Tanaka S, Ban D, Matsumura S, Irie T, Ochiai T, Nakamura N, Arii S, Tanabe M. Kudo A, et al. Among authors: arii s. J Gastroenterol. 2014 Sep;49(9):1352-61. doi: 10.1007/s00535-013-0899-6. Epub 2013 Oct 18. J Gastroenterol. 2014. PMID: 24136219 Clinical Trial.

7

Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.

Akahoshi K, Tanaka S, Mogushi K, Shimada S, Matsumura S, Akiyama Y, Aihara A, Mitsunori Y, Ban D, Ochiai T, Kudo A, Arii S, Tanabe M. Akahoshi K, et al. Among authors: arii s. J Gastroenterol. 2016 Sep;51(9):910-22. doi: 10.1007/s00535-015-1159-8. Epub 2016 Jan 6. J Gastroenterol. 2016. PMID: 26739296

8

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma.

Tanaka S, Arii S. Tanaka S, et al. Among authors: arii s. Int J Clin Oncol. 2006 Apr;11(2):82-9. doi: 10.1007/s10147-006-0566-5. Int J Clin Oncol. 2006. PMID: 16622743 Review.

9

Strong association between frequency of intermittent inflow occlusion and transient increase in serum liver enzymes after hepatic resection.

Teramoto K, Nakamura N, Ito K, Kudo A, Noguchi N, Takamatsu S, Kawamura T, Tanaka S, Arii S. Teramoto K, et al. Among authors: arii s. Hepatogastroenterology. 2008 Mar-Apr;55(82-83):636-40. Hepatogastroenterology. 2008. PMID: 18613423

10

Anterior approach for left-sided hepatic resection.

Tanaka S, Taira K, Kudo A, Nakamura N, Ito K, Arii S. Tanaka S, et al. Among authors: arii s. Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1760-3. Hepatogastroenterology. 2008. PMID: 19102386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters